C12P1/00	7	Preparation of compounds or compositions, not provided for in groups C12P3/00&#160;-&#160;C12P39/00, by using microorganisms or enzymes<br><br><u>NOTE</u><br><br>This group is used for the classification of documents relating to the production of compounds of unknown structure <br>When classifying in this group, classification should be made also in C12R	C12P1/00	C12P1/00		1528
C12P1/02	8	by using fungi	C12P1/02	C12P1/02		2142
C12P1/04	8	by using bacteria	C12P1/04	C12P1/04		3208
C12P1/06	8	by using actinomycetales	C12P1/06	C12P1/06		741
C12P3/00	7	Preparation of elements or inorganic compounds except carbon dioxide {(recovery of carbon dioxides as by-products C12F3/02)}	C12P3/00	C12P3/00		2407
C12P5/00	7	Preparation of hydrocarbons {or halogenated hydrocarbons}	C12P5/00	C12P5/00		223
C12P5/002	8	{cyclic (compounds containing at least three condensed carbocyclic rings C12P15/00)}	C12P5/00	C12P5/00		213
C12P5/005	9	{aromatic (naphthacene C12P29/00)}	C12P5/00	C12P5/00		84
C12P5/007	8	{containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00)}	C12P5/00	C12P5/00		881
C12P5/02	8	acyclic {(C12P5/007 takes precedence)}	C12P5/02	C12P5/02		437
C12P5/023	9	{Methane}	C12P5/02	C12P5/02		3405
C12P5/026	9	{Unsaturated compounds, i.e. alkenes, alkynes or allenes}	C12P5/02	C12P5/02		480
C12P7/00	7	Preparation of oxygen-containing organic compounds	C12P7/00	C12P7/00		282
C12P7/02	8	containing a hydroxy group	C12P7/02	C12P7/02		1036
C12P7/04	9	acyclic	C12P7/04	C12P7/04		1338
C12P7/06	10	Ethanol, i.e. non-beverage	C12P7/06	C12P7/06		2978
C12P7/065	11	{with microorganisms other than yeasts}	C12P7/06	C12P7/06		877
C12P7/08	11	produced as by-product or from waste or cellulosic material substrate	C12P7/08	C12P7/08		592
C12P7/10	12	substrate containing cellulosic material	C12P7/10	C12P7/10		2773
C12P7/12	12	substrate containing sulfite waste liquor or citrus waste	C12P7/12	C12P7/12		88
C12P7/14	11	Multiple stages of fermentation; Multiple types of microorganisms or re-use of microorganisms	C12P7/14	C12P7/14		513
C12P7/16	10	Butanols	C12P7/16	C12P7/16		1344
C12P7/18	10	polyhydric	C12P7/18	C12P7/18		1878
C12P7/20	11	Glycerol	C12P7/20	C12P7/20		337
C12P7/22	9	aromatic	C12P7/22	C12P7/22		1727
C12P7/24	8	containing a carbonyl group	C12P7/24	C12P7/24		867
C12P7/26	9	Ketones	C12P7/26	C12P7/26		1314
C12P7/28	10	Acetone-containing products	C12P7/28	C12P7/28		544
C12P7/30	11	produced from substrate containing inorganic compounds other than water	C12P7/30	C12P7/30		14
C12P7/32	11	produced from substrate containing inorganic nitrogen source	C12P7/32	C12P7/32		1
C12P7/34	11	produced from substrate containing protein as nitrogen source	C12P7/34	C12P7/34		3
C12P7/36	11	produced from substrate containing grain or cereal material	C12P7/36	C12P7/36		35
C12P7/38	10	Cyclopentanone- or cyclopentadione-containing products	C12P7/38	C12P7/38		62
C12P7/40	8	containing a carboxyl group {including Peroxycarboxylic acids}	C12P7/40	C12P7/40		2337
C12P7/42	9	Hydroxy-carboxylic acids	C12P7/42	C12P7/42		2488
C12P7/44	9	Polycarboxylic acids	C12P7/44	C12P7/44		805
C12P7/46	10	Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid	C12P7/46	C12P7/46		1091
C12P7/48	10	Tricarboxylic acids, e.g. citric acid	C12P7/48	C12P7/48		551
C12P7/50	10	having keto groups, e.g. 2-ketoglutaric acid	C12P7/50	C12P7/50		196
C12P7/52	9	Propionic acid; Butyric acids	C12P7/52	C12P7/52		1004
C12P7/54	9	Acetic acid (vinegar C12J)	C12P7/54	C12P7/54		963
C12P7/56	9	Lactic acid	C12P7/56	C12P7/56		1702
C12P7/58	9	Aldonic, ketoaldonic or saccharic acids (uronic acids C12P19/00)	C12P7/58	C12P7/58		430
C12P7/60	10	2-Ketogulonic acid	C12P7/60	C12P7/60		172
C12P7/62	8	Carboxylic acid esters	C12P7/62	C12P7/62		2207
C12P7/625	9	Polyesters of hydroxy carboxylic acids	C12P7/625	C12P7/625		1413
C12P7/64	8	Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats	C12P7/64	C12P7/64		945
C12P7/6409	9	Fatty acids	C12P7/6409	C12P7/6409		1173
C12P7/6418	10	by hydrolysis of fatty acid esters	C12P7/6418	C12P7/6418		262
C12P7/6427	10	Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone	C12P7/6427	C12P7/6427		806
C12P7/6431	11	Linoleic acids [18:2[n-6]]	C12P7/6431	C12P7/6431		149
C12P7/6432	11	Eicosapentaenoic acids [EPA]	C12P7/6432	C12P7/6432		309
C12P7/6434	11	Docosahexenoic acids [DHA]	C12P7/6434	C12P7/6434		344
C12P7/6436	9	Fatty acid esters	C12P7/6436	C12P7/6436		627
C12P7/6445	10	Glycerides	C12P7/6445	C12P7/6445		273
C12P7/6454	11	by esterification	C12P7/6454	C12P7/6454		370
C12P7/6458	11	by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis	C12P7/6458	C12P7/6458		526
C12P7/6463	11	obtained from glyceride producing microorganisms, e.g. single cell oil	C12P7/6463	C12P7/6463		1084
C12P7/6472	11	containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone	C12P7/6472	C12P7/6472		763
C12P7/6481	11	Phosphoglycerides (phosphoglycerides having carboxylic acids with less than seven carbon atoms C12P7/62)	C12P7/6481	C12P7/6481		257
C12P7/649	10	Biodiesel, i.e. fatty acid alkyl esters	C12P7/649	C12P7/649		916
C12P7/66	8	containing the quinoid structure	C12P7/66	C12P7/66		407
C12P9/00	7	Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen {(phosphoglycerides, C12P7/6481)}	C12P9/00	C12P9/00		495
C12P11/00	7	Preparation of sulfur-containing organic compounds	C12P11/00	C12P11/00		461
C12P13/00	7	Preparation of nitrogen-containing organic compounds	C12P13/00	C12P13/00		547
C12P13/001	8	{Amines; Imines}	C12P13/00	C12P13/00		1471
C12P13/002	8	{Nitriles (-CN)}	C12P13/00	C12P13/00		202
C12P13/004	9	{Cyanohydrins}	C12P13/00	C12P13/00		120
C12P13/005	8	{Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids}	C12P13/00	C12P13/00		795
C12P13/007	8	{Carnitine; Butyrobetaine; Crotonobetaine}	C12P13/00	C12P13/00		59
C12P13/008	8	{containing a N-O bond, e.g. nitro (-NO2), nitroso (-NO)}	C12P13/00	C12P13/00		140
C12P13/02	8	Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)}	C12P13/02	C12P13/02		1662
C12P13/04	8	Alpha- or beta- amino acids {(other amino acids C12P13/005)}	C12P13/04	C12P13/04		2686
C12P13/06	9	Alanine; Leucine; Isoleucine; Serine; Homoserine	C12P13/06	C12P13/06		1256
C12P13/08	9	Lysine; Diaminopimelic acid; Threonine; Valine	C12P13/08	C12P13/08		2041
C12P13/10	9	Citrulline; Arginine; Ornithine	C12P13/10	C12P13/10		489
C12P13/12	9	Methionine; Cysteine; Cystine	C12P13/12	C12P13/12		623
C12P13/14	9	Glutamic acid; Glutamine	C12P13/14	C12P13/14		1136
C12P13/16	10	using surfactants, fatty acids or fatty acid esters, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group or a carboxyl ester group	C12P13/16	C12P13/16		28
C12P13/18	10	using biotin or its derivatives	C12P13/18	C12P13/18		67
C12P13/20	9	Aspartic acid; Asparagine	C12P13/20	C12P13/20		276
C12P13/22	9	Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine<br><br><u>NOTE</u><br><br> Processes for the preparation of different amino acids covered by more than one of the groups C12P13/222&#160;-&#160;C12P13/227 are classified in group C12P13/22	C12P13/22	C12P13/22		303
C12P13/222	10	{Phenylalanine}	C12P13/22	C12P13/22		308
C12P13/225	10	{Tyrosine; 3,4-Dihydroxyphenylalanine}	C12P13/22	C12P13/22		212
C12P13/227	10	{Tryptophan}	C12P13/22	C12P13/22		459
C12P13/24	9	Proline; Hydroxyproline; Histidine	C12P13/24	C12P13/24		371
C12P15/00	7	Preparation of compounds containing at least three condensed carbocyclic rings {(gibbanes C12P27/00; naphthacenes C12P29/00)}	C12P15/00	C12P15/00		386
C12P17/00	7	Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms (C12P13/04&#160;-&#160;C12P13/24 take precedence)	C12P17/00	C12P17/00		217
C12P17/02	8	Oxygen as only ring hetero atoms	C12P17/02	C12P17/02		695
C12P17/04	9	containing a five-membered hetero ring, e.g. griseofulvin {, vitamin C}	C12P17/04	C12P17/04		1255
C12P17/06	9	containing a six-membered hetero ring, e.g. fluorescein	C12P17/06	C12P17/06		2267
C12P17/08	9	containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons	C12P17/08	C12P17/08		332
C12P17/10	8	Nitrogen as only ring hetero atom	C12P17/10	C12P17/10		1585
C12P17/12	9	containing a six-membered hetero ring	C12P17/12	C12P17/12		1372
C12P17/14	8	Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring	C12P17/14	C12P17/14		231
C12P17/16	8	containing two or more hetero rings {(thiamine open chain analogs C12P17/167, i.e. not condensed among themselves or through a common carbocyclic ring system)}	C12P17/16	C12P17/16		329
C12P17/162	9	{Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid}	C12P17/16	C12P17/16		380
C12P17/165	9	{Heterorings having nitrogen atoms as the only ring heteroatoms}	C12P17/16	C12P17/16		540
C12P17/167	9	{Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs}	C12P17/16	C12P17/16		87
C12P17/18	8	containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin {(e.g. Rifamycin C12P17/189)}	C12P17/18	C12P17/18		530
C12P17/181	9	{Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin}	C12P17/18	C12P17/18		883
C12P17/182	9	{Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00)}	C12P17/18	C12P17/18		878
C12P17/183	10	{containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus}	C12P17/18	C12P17/18		137
C12P17/184	10	{containing a beta-lactam ring, e.g. thienamycin}	C12P17/18	C12P17/18		99
C12P17/185	9	{Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system (cepam nucleus C12P35/00; penam nucleus C12P37/00)}	C12P17/18	C12P17/18		56
C12P17/186	10	{containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin}	C12P17/18	C12P17/18		62
C12P17/187	10	{containing two or more directly linked sulfur atoms, e.g. epithiopiperazines}	C12P17/18	C12P17/18		10
C12P17/188	9	{Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms (ergot-alcaloids C12P17/183)}	C12P17/18	C12P17/18		619
C12P17/189	10	{containing the rifamycin nucleus}	C12P17/18	C12P17/18		32
C12P19/00	7	Preparation of compounds containing saccharide radicals (ketoaldonic acids C12P7/58)<br><br><u>NOTE</u><br><br> Attention is drawn to the term "saccharide radical" in the first Note following the title of subclass C07H. 	C12P19/00	C12P19/00		1828
C12P19/02	8	Monosaccharides (2-ketogulonic acid C12P7/60)	C12P19/02	C12P19/02		4535
C12P19/04	8	Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds	C12P19/04	C12P19/04		6470
C12P19/06	9	Xanthan, i.e. Xanthomonas-type heteropolysaccharides	C12P19/06	C12P19/06		320
C12P19/08	9	Dextran	C12P19/08	C12P19/08		364
C12P19/10	9	Pullulan	C12P19/10	C12P19/10		80
C12P19/12	8	Disaccharides	C12P19/12	C12P19/12		1739
C12P19/14	8	produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}	C12P19/14	C12P19/14		6476
C12P19/16	8	produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin (non-biological hydrolysis of starch C08B30/00)	C12P19/16	C12P19/16		503
C12P19/18	8	produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins	C12P19/18	C12P19/18		1890
C12P19/20	8	produced by the action of an exo-1,4 alpha-glucosidase, e.g. dextrose	C12P19/20	C12P19/20		501
C12P19/22	8	produced by the action of a beta-amylase, e.g. maltose	C12P19/22	C12P19/22		300
C12P19/24	8	produced by the action of an isomerase, e.g. fructose	C12P19/24	C12P19/24		1113
C12P19/26	8	Preparation of nitrogen-containing carbohydrates	C12P19/26	C12P19/26		2064
C12P19/28	9	N-glycosides	C12P19/28	C12P19/28		244
C12P19/30	10	Nucleotides	C12P19/30	C12P19/30		522
C12P19/305	11	{Pyrimidine nucleotides}	C12P19/30	C12P19/30		263
C12P19/32	11	having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide	C12P19/32	C12P19/32		781
C12P19/34	11	Polynucleotides, e.g. nucleic acids, oligoribonucleotides	C12P19/34	C12P19/34		3130
C12P19/36	11	Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate	C12P19/36	C12P19/36		235
C12P19/38	10	Nucleosides	C12P19/38	C12P19/38		186
C12P19/385	11	{Pyrimidine nucleosides}	C12P19/38	C12P19/38		194
C12P19/40	11	having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides	C12P19/40	C12P19/40		589
C12P19/42	10	Cobalamins, i.e. vitamin B12, LLD factor	C12P19/42	C12P19/42		397
C12P19/44	8	Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)}	C12P19/44	C12P19/44		1554
C12P19/445	9	{The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin}	C12P19/44	C12P19/44		100
C12P19/46	9	having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin	C12P19/46	C12P19/46		124
C12P19/48	10	the cyclohexyl radical being substituted by two or more nitrogen atoms, e.g. destomycin, neamin	C12P19/48	C12P19/48		43
C12P19/485	11	{Having two saccharide radicals bound through only oxygen to non-adjacent ring carbons of the cyclohexyl radical, e.g. gentamycin, kanamycin, sisomycin, verdamycin, mutamycin, tobramycin, nebramycin, antibiotics 66-40B, 66-40D, XK-62-2, 66-40, G-418, G-52 (see also C12P19/54)}	C12P19/48	C12P19/48		88
C12P19/50	11	having two saccharide radicals bound through only oxygen to adjacent ring carbon atoms of the cyclohexyl radical, e.g. ambutyrosin, ribostamycin	C12P19/50	C12P19/50		14
C12P19/52	12	containing three or more saccharide radicals, e.g. neomycin, lividomycin	C12P19/52	C12P19/52		37
C12P19/54	10	the cyclohexyl radical being bound directly to a nitrogen atom of two or more  radicals, e.g. streptomycin	C12P19/54	C12P19/54		86
C12P19/56	9	having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin	C12P19/56	C12P19/56		682
C12P19/58	9	having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin	C12P19/58	C12P19/58		72
C12P19/60	9	having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin {(C12P19/605)}	C12P19/60	C12P19/60		771
C12P19/605	10	{to a 1-benzopyran-2-on (or the chalcones and hydrogenated chalcones thereof, e.g. coumermycin, novobiocin, novenamin)}	C12P19/60	C12P19/60		40
C12P19/62	10	the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin	C12P19/62	C12P19/62		667
C12P19/623	11	{Avermectin; Milbemycin; Ivermectin; C-076}	C12P19/62	C12P19/62		125
C12P19/626	11	{Natamycin; Pimaricin; Tennecetin}	C12P19/62	C12P19/62		57
C12P19/64	8	Preparation of S-glycosides, e.g. lincomycin	C12P19/64	C12P19/64		68
C12P21/00	7	Preparation of peptides or proteins (single cell protein C12N1/00)	C12P21/00	C12P21/00		3591
C12P21/005	8	{Glycopeptides, glycoproteins}	C12P21/00	C12P21/00		1199
C12P21/02	8	having a known sequence of two or more amino acids, e.g. glutathione	C12P21/02	C12P21/02		6101
C12P21/06	8	produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00)	C12P21/06	C12P21/06		7896
C12P23/00	7	Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes (containing heterorings C12P17/00)	C12P23/00	C12P23/00		1596
C12P25/00	7	Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin	C12P25/00	C12P25/00		283
C12P27/00	7	Preparation of compounds containing a gibbane ring system, e.g. gibberellin	C12P27/00	C12P27/00		127
C12P29/00	7	Preparation of compounds containing a naphthacene ring system, e.g. tetracycline (C12P19/00 takes precedence)	C12P29/00	C12P29/00		342
C12P31/00	7	Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins	C12P31/00	C12P31/00		98
C12P31/005	8	{by fermentation or enzyme-using processes from marine organisms, e.g. Plexaura Homomalla}	C12P31/00	C12P31/00		4
C12P33/00	7	Preparation of steroids<br><br><u>NOTE</u><br><br> Attention is drawn to Note (1) following the title of subclass C07J, which explains what is covered by the term "steroids".<br> In groups C12P33/02 - C12P33/20, the following terms are used with the meaning indicated:<br>"acting", "forming", "hydroxylating", "dehydroxylating" or "dehydrogenating" means the action of a microorganism or enzyme rather than other chemical action.<br>In groups C12P33/005 - C12P33/20, the last place priority rule does not apply. Classification may be made in more than one place within C12P33/00 - C12P33/18, in contrast to the general last place rule that applies throughout C12P.<br>This Note corresponds to IPC Note (1) relating to C12P3/00 - C12P37/00.	C12P33/00	C12P33/00		1875
C12P33/005	8	{Degradation of the lateral chains at position 17}	C12P33/00	C12P33/00		138
C12P33/02	8	Dehydrogenating; Dehydroxylating	C12P33/02	C12P33/02		419
C12P33/04	9	Forming an aryl ring from A ring	C12P33/04	C12P33/04		17
C12P33/06	8	Hydroxylating	C12P33/06	C12P33/06		463
C12P33/08	9	at 11 position	C12P33/08	C12P33/08		112
C12P33/10	10	at 11 alpha-position	C12P33/10	C12P33/10		136
C12P33/12	8	Acting on D ring {(carbons 13 and 14 belong to the C ring; degradation of lateral chains C12P33/005)}	C12P33/12	C12P33/12		44
C12P33/14	9	Hydroxylating at 16 position	C12P33/14	C12P33/14		28
C12P33/16	9	Acting at 17 position	C12P33/16	C12P33/16		91
C12P33/18	10	Hydroxylating at 17 position	C12P33/18	C12P33/18		51
C12P33/20	8	containing heterocyclic rings	C12P33/20	C12P33/20		782
C12P35/00	7	Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin	C12P35/00	C12P35/00		205
C12P35/02	8	by desacylation of the substituent in the 7 position	C12P35/02	C12P35/02		138
C12P35/04	8	by acylation of the substituent in the 7 position	C12P35/04	C12P35/04		125
C12P35/06	8	Cephalosporin C; Derivatives thereof	C12P35/06	C12P35/06		181
C12P35/08	8	disubstituted in the 7 position	C12P35/08	C12P35/08		54
C12P37/00	7	Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin	C12P37/00	C12P37/00		290
C12P37/02	8	in presence of phenylacetic acid or phenylacetamide or their derivatives {not to be used}	C12P37/02	C12P37/02		17
C12P37/04	8	by acylation of the substituent in the 6 position	C12P37/04	C12P37/04		100
C12P37/06	8	by desacylation of the substituent in the 6 position	C12P37/06	C12P37/06		101
C12P39/00	7	Processes involving microorganisms of different genera in the same process, simultaneously	C12P39/00	C12P39/00		1835
C12P41/00	7	Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture	C12P41/00	C12P41/00		403
C12P41/001	8	{by metabolizing one of the enantiomers}	C12P41/00	C12P41/00		313
C12P41/002	8	{by oxidation/reduction reactions}	C12P41/00	C12P41/00		473
C12P41/003	8	{by ester formation, lactone formation or the inverse reactions}	C12P41/00	C12P41/00		92
C12P41/004	9	{by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction}	C12P41/00	C12P41/00		423
C12P41/005	9	{by esterification of carboxylic acid groups in the enantiomers or the inverse reaction}	C12P41/00	C12P41/00		411
C12P41/006	8	{by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures}	C12P41/00	C12P41/00		282
C12P41/007	9	{by reactions involving acyl derivatives of racemic amines}	C12P41/00	C12P41/00		189
C12P41/008	9	{by reactions involving carbamates}	C12P41/00	C12P41/00		8
C12P41/009	9	{by reactions involving hydantoins or carbamoylamino compounds}	C12P41/00	C12P41/00		55
C12P2201/00	7	Pretreatment of cellulosic or lignocellulosic material for subsequent enzymatic treatment or hydrolysis	CPCONLY	C12P2201/00		2088
C12P2203/00	7	Fermentation products obtained from optionally pretreated or hydrolyzed cellulosic or lignocellulosic material as the carbon source	CPCONLY	C12P2203/00		1436
